牛呼吸道疾病治疗药物市场：依疾病类型、治疗类型、通路 - 2025-2030 年全球预测

2023年牛呼吸道疾病治疗市值为19.6亿美元，预计到2024年将达到21亿美元，复合年增长率为7.58%，预计到2030年将达到32.7亿美元。

牛呼吸道疾病 (BRD) 治疗市场广阔，涵盖各种旨在管理和预防牛中这种常见疾病的药物和生物解决方案。 BRD 是家牛业的一个严重健康问题，由于生产力下降和死亡率增加而影响动物福利和经济，因此需要介入。主要用途是疫苗等预防措施以及抗生素和发炎药物等治疗。最终用途范围包括兽医医院、专科诊所和大型家牛，根据农场特定的 BRD 情况整合客製化治疗的趋势日益明显。

促进市场成长的主要因素包括生物技术的进步、动物健康意识的提高以及对永续农业实践的日益重视。此外，监管转向减少牲畜中抗生素的使用，这既是挑战，也是增长的机会。整合 BRD 预测和诊断的农场管理软体等技术创新提供了充满希望的机会。专注于开发具有成本效益的频谱疫苗和增强快速诊断的公司有望在这个发展中市场中获得优势。

然而，严格的法律规范、开发新药的高成本以及抗药性BRD菌株的出现等挑战构成了重大障碍。此外，新兴国家对先进治疗方法的认识较低限制了市场潜力。最佳创新领域包括培育抗病牛的遗传进展、新型生物治疗药物和配方的开发以及用于精准牲畜健康管理的数位工具。旨在增加开拓市场采用新技术的合作研究项目和有针对性的教育宣传活动对于寻求保持竞争力的公司至关重要。鑑于该市场的动态性质，持续监控监管变化和动物用药品开发对于您业务的持续成长至关重要。

市场动态：快速发展的牛呼吸道疾病治疗市场的关键市场洞察

牛呼吸道疾病药物市场正因供需的动态交互作用而转变。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助消费行为及其对製造业的影响。

• 市场驱动因素
  • 牛BRD 盛行率增加
  • 牛肉消费量增加
  • 环境因素的变化
• 市场限制因素
  • 缺乏熟练的兽医
• 市场机会
  • 越来越关注功能疗法的研究和开发
  • 消费者对健康肉类和动物保健的意识不断增强
• 市场挑战
  • 诊断牛呼吸道疾病的复杂性

波特五力：驾驭牛呼吸道疾病药物市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势、解决弱点并避免潜在的挑战，以确保更强大的市场地位。

PESTLE分析：了解外部对牛呼吸道疾病治疗市场的影响

外部宏观环境因素在塑造牛呼吸道疾病治疗药物市场的表现动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解牛呼吸道疾病治疗药物市场的竞争状况

对牛呼吸道疾病治疗药物市场的详细市场占有率分析可以对供应商的表现进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV牛呼吸道疾病治疗药物市场供应商定位矩阵绩效评估

FPNV 定位矩阵是评估牛呼吸道疾病治疗药物市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议，描绘牛呼吸道疾病治疗药物市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对牛呼吸道疾病治疗药物市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监管核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

• 市场动态
  • 促进因素
    • 牛BRD 发生率增加
    • 牛肉消费量增加
    • 改变环境因素
  • 抑制因素
    • 缺乏熟练的兽医
  • 机会
    • 专注于功能治疗方法的研发
    • 消费者对健康肉品和动物保健的意识不断增强
  • 任务
    • 诊断牛呼吸道疾病的复杂性
• 市场区隔分析
• 波特五力分析
• PESTEL分析
  • 政治的
  • 经济
  • 社群
  • 技术的
  • 合法地
  • 环境

第六章牛呼吸道疾病治疗药物市场：依疾病类型

• 白喉
• 肺炎
• 上呼吸道感染疾病

第七章依治疗类型分類的牛呼吸道疾病治疗药物市场

• 抗生素
• 免疫调节剂
• 疫苗

第八章牛呼吸道疾病治疗药物市场：依通路分类

• 诊所
• 医院
• 调查机构

第九章北美和南美牛呼吸道疾病治疗市场

• 阿根廷
• 巴西
• 加拿大
• 墨西哥
• 美国

第十章亚太地区牛呼吸道疾病治疗市场

• 澳洲
• 中国
• 印度
• 印尼
• 日本
• 马来西亚
• 菲律宾
• 新加坡
• 韩国
• 台湾
• 泰国
• 越南

第十一章 欧洲、中东和非洲牛呼吸道疾病治疗市场

• 丹麦
• 埃及
• 芬兰
• 法国
• 德国
• 以色列
• 义大利
• 荷兰
• 奈及利亚
• 挪威
• 波兰
• 卡达
• 俄罗斯
• 沙乌地阿拉伯
• 南非
• 西班牙
• 瑞典
• 瑞士
• 土耳其
• 阿拉伯聯合大公国
• 英国

第十二章竞争格局

• 2023 年市场占有率分析
• FPNV 定位矩阵，2023
• 竞争情境分析
• 战略分析和建议

公司名单

• Bayer AG
• Bimeda Inc.
• Boehringer Ingelheim GmbH
• CEVA Animal Health（Pty）Ltd.
• Dechra Pharmaceuticals PLC
• Elanco Animal Health Incorporated
• Krka UK Ltd
• Merck & Co. Inc.
• Neogen Corporation
• Sanofi SA
• Vetoquinol SA
• Vetstream Ltd
• Virbac Group
• Zinpro Corporation
• Zoetis Inc.

The Bovine Respiratory Disease Treatment Market was valued at USD 1.96 billion in 2023, expected to reach USD 2.10 billion in 2024, and is projected to grow at a CAGR of 7.58%, to USD 3.27 billion by 2030.

The market for Bovine Respiratory Disease (BRD) treatments is vast, encompassing various pharmaceuticals and biological solutions designed to manage and prevent this widespread affliction in cattle. BRD, a significant health concern in the cattle industry, necessitates interventions due to its implications on animal welfare and economic impact, resulting from decreased productivity and increased mortality rates. The applications primarily lie in preventive measures such as vaccines and therapeutic treatments, including antibiotics and anti-inflammatory drugs. End-use scope involves veterinary hospitals, specialized clinics, and large-scale cattle operations, with an increasing trend towards integration of tailored treatments in accordance with farm-specific BRD profiles.

Key influencers of market growth include advancements in biotechnology, increasing awareness about animal health, and the growing emphasis on sustainable agricultural practices. Furthermore, regulatory shifts towards reducing antibiotic use in livestock present both challenges and opportunities for growth; they necessitate innovation in non-antibiotic treatments. Technological innovations, such as farm management software integrating BRD forecasting and diagnostics, offer promising opportunities. Companies focusing on developing cost-effective, broad-spectrum vaccines and enhancing rapid diagnostic methods are poised to excel in this evolving market.

However, challenges such as stringent regulatory frameworks, high costs of new drug development, and the emergence of drug-resistant BRD strains pose significant hurdles. Additionally, limited awareness about advanced treatment options in developing regions restricts market potential. The best areas of innovation include genetic advancements in breeding for disease-resistant herds, development of novel biotherapeutics and formulations, and digital tools for precise livestock health management. For firms aiming to secure a competitive edge, collaborative research ventures and targeted education campaigns aimed at increasing adoption of new technologies in underpenetrated markets are crucial. Given the dynamic nature of this market, continuous monitoring of regulatory changes and animal health trends will be essential for sustainable business growth.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Bovine Respiratory Disease Treatment Market

The Bovine Respiratory Disease Treatment Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing prevalence of BRD among cattle
  • Increasing consumption of beef
  • Changing environmental factors
• Market Restraints
  • Shortage of skilled veterinarians
• Market Opportunities
  • Increasing focus on research and development of functional therapies
  • Growing awareness among consumers about healthy meat and animal health management
• Market Challenges
  • Complexities related to bovine respiratory disease diagnosis

Porter's Five Forces: A Strategic Tool for Navigating the Bovine Respiratory Disease Treatment Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Bovine Respiratory Disease Treatment Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Bovine Respiratory Disease Treatment Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Bovine Respiratory Disease Treatment Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Bovine Respiratory Disease Treatment Market

A detailed market share analysis in the Bovine Respiratory Disease Treatment Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Bovine Respiratory Disease Treatment Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Bovine Respiratory Disease Treatment Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Bovine Respiratory Disease Treatment Market

A strategic analysis of the Bovine Respiratory Disease Treatment Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Bovine Respiratory Disease Treatment Market, highlighting leading vendors and their innovative profiles. These include Bayer AG, Bimeda Inc., Boehringer Ingelheim GmbH, CEVA Animal Health (Pty) Ltd., Dechra Pharmaceuticals PLC, Elanco Animal Health Incorporated, Krka UK Ltd, Merck & Co. Inc., Neogen Corporation, Sanofi S.A., Vetoquinol S.A., Vetstream Ltd, Virbac Group, Zinpro Corporation, and Zoetis Inc..

Market Segmentation & Coverage

This research report categorizes the Bovine Respiratory Disease Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Disease Type, market is studied across Diphtheria, Pneumonia, and Upper Respiratory Tract Infections.
• Based on Treatment Type, market is studied across Antibiotics, Immunomodulators, and Vaccines.
• Based on Distribution Channel, market is studied across Clinics, Hospitals, and Research Institutions.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing prevalence of BRD among cattle
    • 5.1.1.2. Increasing consumption of beef
    • 5.1.1.3. Changing environmental factors
  • 5.1.2. Restraints
    • 5.1.2.1. Shortage of skilled veterinarians
  • 5.1.3. Opportunities
    • 5.1.3.1. Increasing focus on research and development of functional therapies
    • 5.1.3.2. Growing awareness among consumers about healthy meat and animal health management
  • 5.1.4. Challenges
    • 5.1.4.1. Complexities related to bovine respiratory disease diagnosis
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Bovine Respiratory Disease Treatment Market, by Disease Type

• 6.1. Introduction
• 6.2. Diphtheria
• 6.3. Pneumonia
• 6.4. Upper Respiratory Tract Infections

7. Bovine Respiratory Disease Treatment Market, by Treatment Type

• 7.1. Introduction
• 7.2. Antibiotics
• 7.3. Immunomodulators
• 7.4. Vaccines

8. Bovine Respiratory Disease Treatment Market, by Distribution Channel

• 8.1. Introduction
• 8.2. Clinics
• 8.3. Hospitals
• 8.4. Research Institutions

9. Americas Bovine Respiratory Disease Treatment Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Bovine Respiratory Disease Treatment Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Bovine Respiratory Disease Treatment Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Bayer AG
• 2. Bimeda Inc.
• 3. Boehringer Ingelheim GmbH
• 4. CEVA Animal Health (Pty) Ltd.
• 5. Dechra Pharmaceuticals PLC
• 6. Elanco Animal Health Incorporated
• 7. Krka UK Ltd
• 8. Merck & Co. Inc.
• 9. Neogen Corporation
• 10. Sanofi S.A.
• 11. Vetoquinol S.A.
• 12. Vetstream Ltd
• 13. Virbac Group
• 14. Zinpro Corporation
• 15. Zoetis Inc.

LIST OF FIGURES

• FIGURE 1. BOVINE RESPIRATORY DISEASE TREATMENT MARKET RESEARCH PROCESS
• FIGURE 2. BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. BOVINE RESPIRATORY DISEASE TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. BOVINE RESPIRATORY DISEASE TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. BOVINE RESPIRATORY DISEASE TREATMENT MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. BOVINE RESPIRATORY DISEASE TREATMENT MARKET DYNAMICS
• TABLE 7. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY DIPHTHERIA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY PNEUMONIA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY UPPER RESPIRATORY TRACT INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY IMMUNOMODULATORS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY VACCINES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. AMERICAS BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 20. AMERICAS BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 21. AMERICAS BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 22. AMERICAS BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 23. ARGENTINA BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 24. ARGENTINA BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 25. ARGENTINA BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 26. BRAZIL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 27. BRAZIL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 28. BRAZIL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 29. CANADA BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 30. CANADA BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 31. CANADA BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 32. MEXICO BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 33. MEXICO BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 34. MEXICO BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 35. UNITED STATES BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 36. UNITED STATES BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 37. UNITED STATES BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 38. UNITED STATES BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 39. ASIA-PACIFIC BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 40. ASIA-PACIFIC BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 41. ASIA-PACIFIC BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 42. ASIA-PACIFIC BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 43. AUSTRALIA BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 44. AUSTRALIA BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 45. AUSTRALIA BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 46. CHINA BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 47. CHINA BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 48. CHINA BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 49. INDIA BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 50. INDIA BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 51. INDIA BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 52. INDONESIA BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 53. INDONESIA BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 54. INDONESIA BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 55. JAPAN BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 56. JAPAN BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 57. JAPAN BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 58. MALAYSIA BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 59. MALAYSIA BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 60. MALAYSIA BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 61. PHILIPPINES BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 62. PHILIPPINES BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 63. PHILIPPINES BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 64. SINGAPORE BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 65. SINGAPORE BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 66. SINGAPORE BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 67. SOUTH KOREA BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 68. SOUTH KOREA BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 69. SOUTH KOREA BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 70. TAIWAN BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 71. TAIWAN BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 72. TAIWAN BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 73. THAILAND BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 74. THAILAND BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 75. THAILAND BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 76. VIETNAM BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 77. VIETNAM BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 78. VIETNAM BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 79. EUROPE, MIDDLE EAST & AFRICA BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 80. EUROPE, MIDDLE EAST & AFRICA BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 81. EUROPE, MIDDLE EAST & AFRICA BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 82. EUROPE, MIDDLE EAST & AFRICA BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 83. DENMARK BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 84. DENMARK BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 85. DENMARK BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 86. EGYPT BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 87. EGYPT BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 88. EGYPT BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 89. FINLAND BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 90. FINLAND BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 91. FINLAND BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 92. FRANCE BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 93. FRANCE BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 94. FRANCE BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 95. GERMANY BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 96. GERMANY BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 97. GERMANY BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 98. ISRAEL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 99. ISRAEL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 100. ISRAEL BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 101. ITALY BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 102. ITALY BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 103. ITALY BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 104. NETHERLANDS BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 105. NETHERLANDS BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 106. NETHERLANDS BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 107. NIGERIA BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 108. NIGERIA BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 109. NIGERIA BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 110. NORWAY BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 111. NORWAY BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 112. NORWAY BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 113. POLAND BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 114. POLAND BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 115. POLAND BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 116. QATAR BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 117. QATAR BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 118. QATAR BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 119. RUSSIA BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 120. RUSSIA BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 121. RUSSIA BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 122. SAUDI ARABIA BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 123. SAUDI ARABIA BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 124. SAUDI ARABIA BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 125. SOUTH AFRICA BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 126. SOUTH AFRICA BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 127. SOUTH AFRICA BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 128. SPAIN BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 129. SPAIN BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 130. SPAIN BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 131. SWEDEN BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 132. SWEDEN BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 133. SWEDEN BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 134. SWITZERLAND BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 135. SWITZERLAND BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 136. SWITZERLAND BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 137. TURKEY BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 138. TURKEY BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 139. TURKEY BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 140. UNITED ARAB EMIRATES BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 141. UNITED ARAB EMIRATES BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 142. UNITED ARAB EMIRATES BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 143. UNITED KINGDOM BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 144. UNITED KINGDOM BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 145. UNITED KINGDOM BOVINE RESPIRATORY DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 146. BOVINE RESPIRATORY DISEASE TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 147. BOVINE RESPIRATORY DISEASE TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023